Close mobile menu×
Close mobile menu

Rachael A. Safyan, MD

Board Certifications: 
Medical Oncology, Internal Medicine
Expertise in: 
Hematology/Oncology
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New Patients: 
(212) 305-5098
Existing Patients: 
(212) 305-0592

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Medical Oncology
  • Internal Medicine

Clinical Expertise

  • Hematology/Oncology
  • Medical Oncology
  • Stomach Cancer
  • Pancreatic Cancer
  • Liver Cancer
  • Bile Duct Cancer
  • Gallbladder Cancer
  • Cancer of Colon With Rectum
  • Anal Cancer
  • Gastrointestinal Malignancy
  • Internal Medicine

Specialties

Education & Training

  • New York University School of Medicine
  • Internship: Boston University Medical Center
  • Residency: University of Washington Affiliated Hospitals
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Honors & Awards

Burch-Lodge Research Scholar, Columbia University Medical Center (2018)

ASCO/AACR Workshop on Methods in Clinical Cancer Research (2017)

Conquer Cancer Foundation/ASCO Young Investigator Award (2017)

Gold Humanism Honor Society (2014)

About Rachael Safyan

Dr. Rachael Safyan is a medical oncologist specializing in the treatment of gastrointestinal malignancies, with an emphasis on pancreatic and colorectal cancers. She graduated Phi Beta Kappa and summa cum laude from Barnard College of Columbia University, having majored in Neuroscience and Behavior, and received her medical degree from New York University School of Medicine. Dr. Safyan completed an internship in Internal Medicine at Boston Medical Center and a residency in Internal Medicine at the University of Washington, where she was inducted into the Gold Humanism Honor Society. She was then selected to serve as a Chief Resident and Acting Instructor at the University of Washington Medical Center. Dr. Safyan completed her fellowship in Hematology and Medical Oncology at New York-Presbyterian/Columbia University Medical Center, where she was appointed Chief Fellow. During that time, she was awarded a Conquer Cancer Foundation/American Society of Clinical Oncology (ASCO) Young Investigator Award for her work in pancreatic cancer.

Dr. Safyan is actively involved in clinical and translational research. Her focus is on the development and clinical evaluation of novel therapies for patients with gastrointestinal malignancies, particularly colorectal and pancreatic cancers. In addition, she is passionate about medical education and is an Assistant Program Director of the Hematology/Oncology Fellowship. She is also the Director of the Oncology Subinternship and a lecturer for the medical school second-year oncology course The Body in Health and in Disease.

Dr. Safyan’s goal as a clinician and researcher is to improve upon existing treatment strategies. She is proud to offer compassionate and personalized care to each patient alongside CUMC’s dedicated multidisciplinary team.

Academic Titles

  • Assistant Professor of Medicine at CUMC

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Amida Care

  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
161 Fort Washington Avenue
New York, New York 10032
Primary

Research

Grants

A PHASE IB/II, OPEN-LABEL, MULTICENTER, RANDOMIZED UMBRELLA STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE IMMUNOTHERAPY-BASED TREATMENT COMBINATIONS IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MORPHEUS- CRC) (P&S Industry Clinical Trial)

Oct 5 2018 - Oct 5 2023

PHASE II OPEN-LABEL,SINGLE CENTER STUDY EVALUATING SAFETY AND EFFICACY OF PEMBROLIZUMAB FOLLOWING INDCUTION WITH THE HYPOMETHYLATING AGENT AZACITIDINE IN APTIENTS WITH ADVANCED PANCREATIC CANCER AFTER FAILURE OF FIRST LINE THERAPY. (P&S Industry Clinical Trial)

Aug 25 2017 - Aug 25 2022

CLINICAL TRANSLATION OF REGULATORY NETWORK-BASED PRECISION MEDICINE FOR PANCREATIC CANCER (Private)

Apr 1 2018 - Mar 31 2021